Close correlation between anxiety, depression, and asthma control  by Di Marco, Fabiano et al.
Respiratory Medicine (2010) 104, 22e28ava i lab le a t www.sc iencedi rec t .com
journa l homepage : www.e lsev ie r . com/ loca te / rmedClose correlation between anxiety, depression,
and asthma controlFabiano Di Marco a,*, Massimo Verga a, Pierachille Santus a,
Francesca Giovannelli b, Paolo Busatto a, Margherita Neri b,
Giuseppe Girbino c, Sergio Bonini d, Stefano Centanni aa Clinica di Malattie dell’Apparato Respiratorio, Ospedale San Paolo, Universita` degli Studi di Milano, Milano, Italy
b Divisone di Malattie dell’Apparato Respiratorio, IRCCS Fondazione Maugeri, Tradate, Italy
c Clinica di Malattie dell’Apparato Respiratorio, Ospedale Policlinico, Universita` degli Studi di Messina, Messina, Italy
d Seconda Universita` di Napoli, Dipartimento di Medicina Interna, Napoli, Italy
Received 5 June 2009; accepted 13 August 2009




DepressionAbbreviations: ACT, Asthma Control T
ratory volume in 1 s; GINA, Global INit
* Corresponding author at: Ospedale
E-mail address: fabiano.dimarco@
0954-6111/$ - see front matter ª 200
doi:10.1016/j.rmed.2009.08.005Summary
Background: We investigated the correlation between patients’ characteristics, including
anxiety and depression, and the level of asthma control evaluated by asthma control test
(ACT), a self-administered validated questionnaire.
Methods: This is a cross-sectional study on asthmatic outpatients of three Italian hospitals.
Demographic data, spirometry, anxiety and depression scores as well as the level of asthma
control from 315 patients were collected.
Results: Patients with poorly controlled asthma were more frequently women, older, with
a worse pulmonary function, obese, more anxious and/or more depressed. Four different inde-
pendent factors associated with poor asthma control evaluated by ACT have been found:
FEV1 < 60% (odds ratio, OR: 6.52), anxiety (OR: 3.76), age 65 years (OR: 2.69), and depression
(OR: 2.45). The presence of anxiety and depression was associated with a higher healthcare
utilization. Finally, we found a high level of agreement between ACT and multidimensional
GINA approach in evaluating asthma control, with a concordance in 239 patients (81% of the
population).
Conclusion: There is a close correlation between anxiety and depression, and a poor asthma. A
better understanding of this association may have major clinical implications, mainly in
patients with poor controlled asthma in whom the presence of anxiety and depression should
be investigated.
ª 2009 Elsevier Ltd. All rights reserved.est; BMI, body mass index; CI, confidence interval; ED, emergency department; FEV1, forced expi-
iative for Asthma; HAD, Hospital Anxiety and Depression scale; OR, odds ratio; SD, standard deviation.
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Patients’ characteristics and asthma control 23Introduction
committees approved the study and all patients gave writtenThe latest version of the international guidelines on asthma
management (GINA)1 points to the concept that asthma
control is currently considered the target of treatment and
a key point not only to judge the severity of the disease but
also to manage the pharmacological treatment by a step-up
and step-down approach. Some tools have been developed
to quantify asthma control,2e5 such as the Asthma Control
Test (ACT), a validated self-administered questionnaire
that does not include a measure of lung function, designed
to capture the multidimensional nature of asthma control
and to demonstrate good predictive properties for assessing
asthma clinical control.5
Several studies well demonstrated the high prevalence of
psychiatric disorders, mainly anxiety and depression but also
posttraumatic stress disorder, in patients suffering from
asthma6e8; interestingly, the associationbetween asthmaand
psychiatric disorders was also confirmed in a large survey
carried out in 17 countries in Americas, Europe, Middle East,
Asia and South Pacific, that included patients markedly
differing in culture, language and level of socioeconomic
development.9 Another large study demonstrated that chil-
dren and adolescent with asthma have a 2-fold higher risk of
developing at least a depressive or anxiety disorder.10 Some
authors hypothesized that stress associated with chronic
illness increases the likelihood of developing anxiety and
depressive symptoms: notably, it has been demonstrated that
anxiety and depression are more frequent in asthmatic
patients than in patients with other chronic diseases, such as
chronic hepatitis, a pathology that affects patients’ daily
approach to living with the disease.11 Moreover, in patients
with difficult asthma a high prevalence of undiagnosed
psychiatric morbidity, particularly depression, has been
reported12 and, in turn, psychological factors such as anxiety,
depressive disorders and/or personality disorders may
predispose asthmatic patients to near fatal or fatal asthma.13
On the basis of these observations, we investigated the
influence of patients’ characteristics, including anxiety and
depression, on the level of asthma control assessed by
a self-administered questionnaire such as ACT.Methods
Study design and population
This was a cross-sectional study on asthmatic outpatients of
tertiary asthma clinics of three Italian hospitals (San Paolo,
University Hospital, Milan; Policlinico, University Hospital,
Messina, and Fondazione Maugeri, Tradate). Consecutive
patients aged >18 years, diagnosed with asthma of all
severity levels and attending the Respiratory Unit of the
participating hospitals for scheduled visits between January
and April 2007 were enrolled. All patients had symptoms
consistent with the diagnosis of asthma and a>12% increase
in forced expiratory volume in 1 s (FEV1) following 400 mg
of inhaled salbutamol or a provocative concentration of
methacholine causing a 20% fall in FEV1 (PC20) < 8 mg mL
1.
All patients were receiving pharmacological treatment
according to GINA guidelines. The local research ethicsinformed consent.
Data collected
The following data were collected: (1) demographic data
(age, sex, body mass indexe BMI), smoking history, education
level, and atopy; (2) spirometry, performed according to the
ATS/ERS guidelines,14 using predicted values for FEV1 and
forced vital capacity based on the European Coal and Steel
Union reference value15; (3) anxiety and depression level,
assessed with the Hospital Anxiety and Depression scale
(HAD),which is self-reported andhas been extensively used to
screen psychiatric morbidity16 in a diverse range of clinical
groups, including asthmatic patients.17,18 It is comprised of
two parts, the firstwith sevenquestions related toanxietyand
the second with seven questions related to depression. The
maximum score for anxiety and depression is 21; a score8 on
either part was used as a cut-off point for diagnosing anxiety
anddepression16; (4) level of asthmacontrol, assessed by both
Asthma Control Test (ACT)5 and GINA approach1; the latter
includes patient history, physical examination and spirometry
(FEV1: percent of predicted values and relation to the
patients’ personal best). According to GINA guidelines the
disease was defined poorly controlled when three or more
features of partly controlled asthma (diurnal or nocturnal
asthma symptoms, limitations of activities, need for reliever/
rescue treatment, exacerbations, FEV1 < 80% of predicted or
personal best) were present in any of the past 4 weeks. This
evaluation was carried out by treating doctor, strictly on the
basis ofGINA guidelines (Table4.3-1,page58, versionupdated
2007), that was blind about the results of ACT and HAD ques-
tionnaires. The ACT questionnaire is a validated self-admin-
istered questionnaire including five questions related to the
last 4 weeks: episodes of breathlessness, nocturnal awaken-
ings, limitations of daily activities, need for rescue medica-
tion, and patient self-rating of asthma control.
Each question includes five response modalities with
a score ranging from 1 to 5 by increasing the level of asthma
control, so the global arithmetic score ranges from 5 to 25.
Well controlled asthma by ACT was defined by a score 20.5
Analysis
The results are shown as mean  standard deviation (SD)
unless otherwise stated. The sample size was tailored on
the multivariate analysis (see below). On the expected
basis of almost 20% of patients with poorly controlled
asthma, a sample size of 300 patients was estimated in
order to include in the multifactorial analysis at least six
factors (one factor every 10 cases). Continuous variables
were compared using t-test and analysis of variance
(ANOVA) and, if positive, post hoc comparisons were carried
out by t-test with Bonferroni adjustment, and dichotomous
variables using chi-square or a Fischer exact test. For cat-
egorisation of continuous variable international accepted
cut-off values was used (e.g. for FEV1, BMI), whilst for age
the fourth quintile cut-off value was used. A logistic
regression analyses was performed to identify variables
significantly associated with asthma control evaluated by
ACT questionnaire. Variables yielding p-values lower than
24 F. Di Marco et al.0.20 in the univariate analyses were entered into regression
model where not controlled asthma (ACT score <20) was
the outcome variable of interest. Finally, by using Pearson
product moment correlation coefficients, the association
between anxiety, depression and the answer to the fifth
question of ACT (How would you rate your asthma control
during the past 4 weeks?), which reflects the patients’
‘‘perceived’’ level of asthma control, was analysed. All
tests were two-sided, and p-values lower than 0.05 were
considered statistically significant. Statistical tests were
performed using the Statistical Package for Social Sciences
(SPSS, Chicago, USA).
Results
A total of 315 patients were enrolled in the study, but 21
cases were excluded from the analysis for missing data.
Thus, data were available for 294 patients.
Features of enrolled patients according to sex and
asthma control
Table 1 shows the characteristics of the overall population,
such as variables distribution according to sex and asthmaTable 1 Features of enrolled patients.
Characteristics All (%) Females Males
Participants, n (%) 294 198 (67) 96 (33
Age, year 51  17 53  16 47  1
FEV1,
(% of predicted values)
88  13 88  14 88  1
80, n (%) 238 (81) 161 (81) 77 (80
60e80, n (%) 45 (15) 29 (15) 16 (17
<60, n (%) 11 (4) 8 (4) 3 (3)
Atopy, n (%) 190 (65) 124 (63) 66 (69
Asthma duration, year 12  12 14  14 9  8
Smoking: non-smoker 174 (59) 121 (61) 53 (56
Past-smoker 91 (31) 55 (28) 36 (37
Current smoker 29 (10) 22 (11) 7 (7)
BMI (Kg/m2) 25.9  5.9 25.8  6.3 26.0 
25, n (%) 149 (50) 101 (51) 48 (50
25e30, n (%) 96 (33) 63 (32) 33 (35
>30, n (%) 49 (17) 34 (17) 15 (15
ACT total score 20.4  4.5 19.7  4.7 22.0 
Well controlled
by ACT, n (%)
208 (71) 132 (67) 76 (79
Well controlled
asthma by GINA, n (%)
257 (87) 169 (86) 88 (92
Anxious patients, n (%) 114 (39) 96 (49) 18 (19
Depressed patients, n (%) 80 (27) 64 (32) 16 (17
Patients anxious
and depressed, n (%)
54 (18) 48 (24) 6 (6)
1 ED visit* in previous
year, n (%)
24 (8) 21 (11) 3 (3)
 urgent care visit*
in previous year, n (%)
55 (19) 39 (20) 16 (17
Well controlled asthma by ACT: score 20; ED, emergency departmecontrol. As expected, the sample included a majority of
women characterized, in comparison with males, by higher
mean age, longer asthma duration, lower level of asthma
control, higher rate of emergency department visits for
asthma, higher level of anxiety and depression, although
the differences in terms of FEV1, BMI, atopy and smoking
history were not statistically significant. Seventy-one
percent of the enrolled patients referred a well controlled
asthma by ACT (score 20), whilst treating doctors judged
the disease well controlled using the multidimensional GINA
approach in 87% of the sample. As shown in Table 1,
patients with a poorly controlled asthma (ACT score <20)
were more frequently women, older, with a worse pulmo-
nary function and a higher rate of urgent care visits for
asthma, more frequently obese, more anxious and/or more
depressed in comparison with patients with a well
controlled disease (ACT score 20). The level of education
did not result to be significantly associated either with sex,
or with the level of asthma control.
Fig. 1 shows the scores of anxiety and depression
according to the patients’ ‘‘perceived’’ overall level of
asthma control evaluated by the fifth question of ACT (How
would you rate your asthma control during the past
4 weeks?). A constant trend of reduction in anxiety and
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Table 2 Multivariate logistic regression model: risk
factors of poorly controlled asthma (ACT score <20).
Characteristics Odds ratio 95% CI P
Female sex 1.04 0.53e2.04 .901
Age 65 years 2.69 1.40e5.15 .003
FEV1, (% of predicted values)
80 1.00
60e80 .75 0.33e1.70 .487
<60 6.52 1.52e27.92 .012
BMI (Kg/m2)
25 1.00
25e30 1.60 0.84e3.07 .154
>30 1.54 0.74e3.18 .247
Anxiety 3.76 1.98e7.14 <.001
Depression 2.45 1.30e4.62 .006
In bold P < 0.05.
Patients’ characteristics and asthma control 25control, i.e. going from the two lowest level of control (not
controlled at all and poorly controlled asthma) towards
a well controlled asthma (P < .001 for ANOVA analysis, for
both anxiety and depression). The level of FEV1, then, did
not result significantly associated with the level of anxiety
(PZ .244) or depression (PZ .064).
Multivariate analysis for poor asthma control
evaluated by ACT
The multivariate analysis shown in Table 2 includes risk
factors of poorly controlled asthma detected in the
univariate analysis, such as female sex, age 65 years,
anxiety, depression, FEV1, and BMI. From the multivariate
analysis four different independent factors associated with
poor asthma control evaluated by ACT were found:
FEV1 < 60% of the predicted value, anxiety, age 65 years,
and depression (see Table 2); the odds ratio (OR) for poorly
controlled asthma were 6.52, 3.76, 2.69, and 2.45,
respectively.
Features of enrolled patients according to
psychological profile
Table 3 shows the features of patients according to the
psychological profile. More than confirming the association
between the psychological profile and asthma control,
depressed patients were found to be older and more
frequently obese (BMI >30 Kg/m2); moreover, we found
a significant correlation between the psychological profile
and healthcare utilization, with a higher rate of urgent care
visit in patients with concomitant anxiety and depression,
and a higher rate of emergency department visit for asthma
in anxious patients (Table 3).Figure 1 Anxiety and depression (by HAD questionnaire) mean sc
to the perceived level of asthma control evaluated by the 5th quest
past 4 weeks?). (P < .001 for ANOVA analysis, for both anxiety andComparison of ACT and multidimensional GINA
approach in asthma control evaluation
A high agreement of ACT questionnaire in evaluating
asthma control when compared with the multidimensional
GINA approach was found, with a concordance in 239
patients over 294 (81% of the population); in case of
discordance, a lower level of asthma control by ACT was
predominant (54 patients, 18% of the studied population),
whilst the opposite (lower level of asthma control by GINA
approach compared to ACT) was very rare (three patients
corresponding to 1% of studied patients). In this context, no
significant difference between males and females was
found.ore (bars represent the standard errors of the mean) according
ion of ACT (How would you rate your asthma control during the
depression).
Table 3 Features of enrolled patients according to the psychological profile.
Characteristics No disorder Anxiety Depression Anxiety and depression P
Participants, n (%) 154 (52) 60 (20) 26 (9) 54 (18)
Age, year 49  18 50  15 61  14 53  15 .006
65, n (%) 40 (26) 10 (17) 12 (46) 16 (30) .038
FEV1
(% of predicted values)
89  12 89  12 84  18 88  15 .356
80, n (%) 126 (82) 52 (87) 18 (70) 42 (78) .273
60e80, n (%) 24 (15) 7 (11) 5 (19) 9 (17)
<60, n (%) 4 (3) 1 (2) 3 (11) 2 (6)
Atopy, n (%) 101 (66) 37 (62) 15 (58) 37 (69) .754
Asthma duration, year 11  11 14  14 14  17 13  12 .390
Smoking: non-smoker 90 (59) 36 (60) 17 (65) 31 (57) .993
Past-smoker 48 (31) 19 (32) 7 (27) 17 (31)
Current smoker 16 (10) 5 (8) 2(8) 6 (11)
BMI (Kg/m2) 25.5  5.5 26.0  5.4 26.2  7.0 26.8  7.0 .554
25, n (%) 85 (55) 25 (42) 13 (50) 26 (48) .032
25e30, n (%) 48 (31) 28 (47) 5 (19) 15 (28)
>30, n (%) 21 (14) 7 (11) 8 (31) 13 (24)
Well controlled
asthma by GINA, n (%)
144 (93) 50 (83) 22 (85) 41 (76) .005
1 ED visit* in previous year, n (%) 2 (1) 16 (27) 1 (4) 5 (9) <.001
 urgent care visit*
in previous year, n (%)
23 (15) 9 (15) 4 (15) 19 (35) .008
ED, emergency department; *visit for asthma; in bold P < 0.05.
26 F. Di Marco et al.As shown in Fig. 2, patients with a well controlled
asthma according to GINA approach but not by ACT showed
a psychological profile similar to that of patients with
a poorly controlled asthma as judged by both ACT and GINA
approach, i.e. their anxiety and depression score was
significantly higher in comparison with well controlled
patients by both GINA approach and ACT. Notably, the
percentage of anxiety and depression was double in these
patients with GINA/ACT discordance in comparison with
patients with a normal perception of a well controlled
disease evaluated by GINA approach (percentage of anxious
patients: 63.5 vs. 33.5%, and of depressed patients 48.1 vs.
22.7%, respectively, P < .001 for both the comparisons).Discussion
The aim of this study was to investigate the correlation
between patients’ characteristics, including anxiety and
depression, and the level of asthma control evaluated by
ACT. The results of this study show a significant correlation
between a poor level of asthma control and both anxiety
(OR: 3.76) and depression (OR: 2.45), which are frequent
disorders in asthmatic subjects. Moreover, the presence of
anxiety and depression was associated with a higher
healthcare utilization.
Lavoie et al.19 found that depressive and anxiety disor-
ders are independently associated with low asthma-related
quality of life, but that only depressive disorders are
independently associated with low levels of asthma
control. In particular, a trend toward a greater bronchodi-
lator use was observed in patients with anxiety disorders
(despite having better overall levels of asthma control)
than in patients with depressive disorders.The close relation between anxiety, depression and
asthma control we have found becomes more evident in the
light of the conclusions by Laforest et al.,20 who investigated
the relationships between asthma control and patients
characteristics or asthma management. The authors
observed that female sex, active smoking and overweight
status are independent patient’-related determinants of low
disease control. Interestingly, the highest odds ratio was 3.55
for active smoking (10 cigarettes daily), close to the odds
ratio we found for anxiety, 3.76. In this regard, active
smoking is worldwide considered a major determinant for
poor asthma control, due to worsening of the underlying
bronchial inflammation. However, in our study only a limited
number of asthmatic patients was exposed to significant
active smoking (10 cigarettes daily), whilst anxiety and
depression are indeed frequent in asthmatic patients.
Notably, we found a prevalence of anxiety and depression of
39 and 27%, respectively. Cooper et al.,21 using the same
questionnaire (HAD) found a score higher than 8 for anxiety
and depression respectively in 47 and 22% of the asthmatic
population, and Baiardini et al. reported a prevalence of
anxiety and depression of 34.9 and 32.3%, respectively.22
The correlation betweenpsychiatric disorders andasthma
can be explained on the basis of the following hypotheses23:
1. psychiatric disorders such as anxiety and depression
may increase the perception of symptoms thereby
reducing the perception of asthma control level;
2. poorly controlled asthma may lead to an increase in
anxiety and/or depression.
Even if our study was not specifically designed to answer
to this question, the higher prevalence of anxiety and
depression in patients with a not well controlled asthma by
Figure 2 Anxiety and depression (by HAD questionnaire) mean score (bars represent the standard errors of the mean) according
to asthma control evaluated by GINA approach and ACT questionnaire. ns, not significant.
Patients’ characteristics and asthma control 27ACT but controlled according to multidimensional GINA
approach (Fig. 2) in one hand, and the lack of correlation
between pulmonary function test and anxiety and depres-
sion (Table 3) in the other hand, may favour the first
hypothesis. Thus, on this basis, anxiety or depression may
result in poor level of asthma control.
Other factors may also play a role in the relationship
between psychiatric disorders and asthma control. For
example, it has been shown that asthmatic patients with
concomitant depression are less likely to adhere to
medication regiments22,24 and more likely to require
emergency services25 in comparison with asthmatics
patients without depression. Moreover, some studies
suggest an autonomic or immunologic mechanism linking
depression and poor asthma control, i.e. an increased
production of proinflammatory cytokines, even if definitive
data are still missing.26e29 Anxiety, on the other hand, may
lead to a condition of hypervigilance to bodily sensation30
and may emphasize minimal respiratory fluctuation
considered normal by patients without anxiety disorders.
As expected, the level of asthma control resulted to be
significantly correlated with healthcare utilization; more-
over, we found a significant association between the
psychological profile (anxiety and depression) and urgent
care or emergency department visits for asthma. This result
agrees with previous studies11; interestingly, it has been
recently demonstrated that youth with asthma and
depressive disorders have significantly higher health care
utilization and costs, and that most of them are due to
increase in non-mental health and non-asthma expenses.31
In our study, a higher level of asthma control was found
in comparison with other investigations carried out also in
primary care,20 even if it should be underlined that the
three centers participating to the study were tertiary
asthma clinics, with an anti-smoking center: this is why our
population included only 8% of current smokers, with only3% of enrolled patients smoking more than 10 cigarettes/
day. Consequently, we did not find smoking history as one
of the independent factors associated with poorly
controlled asthma, probably for the low rate of active
smoking patients in our sample.
Our results also confirm the significant difference between
males and females both in terms of asthma control and
psychological profile. This is in line with the data by Laforest
et al.,20 indicating female sex as an independent factor
associated with poorly controlled asthma, with an odds ratio
of 1.63, such as also in the study of McCoy et al.32 Then,
a consistent body of literature found a higher prevalence of
anxiety and depression in females compared to males.9,11,19
Finally, we confirmed the high reliability of ACT5 as
a screening questionnaire for the evaluation of asthma
control, strongly concordant with the GINA approach;
discordant cases were mainly due to an overestimation of
asthma severity by ACT, whereas underestimation of asthma
severity by ACTewhich may expose the patient to the risk of
undertreatment e was extremely rare (1% of patients).
Our study may have some potential limitations. First,
anxiety and depression have been evaluated with a simple
questionnaire and not with a structured interview or with
other questionnaires. However, HAD scale has been
successfully used in several clinical groups, including asth-
matic patients17,18; furthermore, Lavoie et al.19 confirmed
the accuracy of two similar questionnaires, the Beck
Depression Inventory-II (BDI-II) and the anxiety sensitivity
index (ASI), by comparing the obtained results with those
from a structured interview.19 Second, patients enrolled
came from tertiary asthma clinics, a factor that may limit
the external validity of our result. However, the inclusion of
more than 300 consecutive outpatients reduces the risk of
patients’ selection bias. Then, we did not analyse, even if
available, data according to patients’ treatment, since the
choice of therapy is closely associated with the level of
28 F. Di Marco et al.asthma control itself. Finally, the present study is not
prospective but cross-sectional. However, our results on
the prevalence of psychological disorder in asthmatic
patients and the relation between these disorders and
asthma control are in line, as previously discussed, with
results from large and sometimes prospective studies.
In conclusion, we found that anxiety and depression are
frequent in asthmatic patients, are associated with a higher
healthcare utilization, and that there is a significant
correlation between these disorders and a poor asthma
control evaluated by ACT. A better understanding of this
association may have major clinical implications, mainly in
patients with poor asthma control in whom the presence of
anxiety and depression should be investigated.
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